Larimar Therapeutics Inc. buy BiotechBee
Start price
20.09.22
/
60%
€3.18
Target price
31.08.25
€7.00
Performance (%)
32.08%
End price
05.05.23
€4.20
Summary
This prediction ended on 05.05.23 with a price of €4.20. With a performance of 32.08% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Larimar Therapeutics Inc. where he still thinks Larimar Therapeutics Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Larimar Therapeutics Inc. | -6.107% | -6.107% | 49.272% |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% |
According to BiotechBee what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zafgen Inc. diskutieren
In the thread Trading Zafgen Inc.
Current prediction by BiotechBee for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.00
04.02.24
04.02.24
€7.00
31.03.26
31.03.26
2.50%
19.04.24
19.04.24
Could be very worthwhile Investment >20% year
